The prevention of atherosclerotic cardiovascular disease (ASCVD) is a critical component of diabetes mellitus management, as individuals with diabetes are at increased risk of developing ASCVD. The Endocrine Society has developed clinical practice guidelines for the prevention of ASCVD in diabetes mellitus, which provides evidence-based recommendations for the management of dyslipidemia, hypertension, and hyperglycemia in individuals with diabetes. This question bank is designed to help healthcare professionals prepare for board exams and improve their clinical knowledge and decision-making skills by testing their understanding of the key concepts and recommendations presented in the Endocrine Society’s guideline. The question bank includes a variety of clinical vignettes and scenarios that cover the management of dyslipidemia, hypertension, and hyperglycemia in individuals with diabetes, and it is updated regularly to ensure that it reflects the most up-to-date information and guidelines.
Prevention of ASCVD in Diabetes Mellitus
Cite this article
MD A.. Prevention of ASCVD in Diabetes Mellitus. My Endo Consult. Published March 6, 2023. Accessed October 21, 2026. https://myendoconsult.com/learn/courses/prevention-of-ascvd-in-diabetes-mellitus/
MD A. (2023). Prevention of ASCVD in Diabetes Mellitus. My Endo Consult. https://myendoconsult.com/learn/courses/prevention-of-ascvd-in-diabetes-mellitus/
MD A.. Prevention of ASCVD in Diabetes Mellitus [Internet]. My Endo Consult; March 6, 2023 [cited October 21, 2026]. Available from: https://myendoconsult.com/learn/courses/prevention-of-ascvd-in-diabetes-mellitus/
@online{myendoconsult4413573,
author = {Akuffo Quarde, MD},
title = {Prevention of ASCVD in Diabetes Mellitus},
organization = {My Endo Consult},
year = {2023},
url = {https://myendoconsult.com/learn/courses/prevention-of-ascvd-in-diabetes-mellitus/},
urldate = {October 21, 2026}
}


